Loading clinical trials...
Loading clinical trials...
Digital PCR-Based Detection of CHIP and MR Mutations for Minimal Residual Disease Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia
Conditions
Interventions
Individualized Digital PCR (dPCR) monitoring
Locations
1
China
Peking University People's Hospital
Beijing, Beijing Municipality, China
Start Date
March 20, 2026
Primary Completion Date
December 31, 2027
Completion Date
December 31, 2029
Last Updated
March 30, 2026
NCT05768932
NCT07451912
NCT06660368
NCT05143996
NCT07198867
NCT06398457
Lead Sponsor
Peking University People's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions